Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trialDavid A. Palma, Suresh Senan, Stephen Harrow et al.|BMC Cancer|2019Cited by 267
Cytotoxicity and Radiosensitizing Activity of the Fatty Acid Synthase Inhibitor C75 Is Enhanced by Blocking Fatty Acid Uptake in Prostate Cancer CellsColin Rae, Anthony J. Chalmers|Advances in Radiation Oncology|2020Cited by 45